| Cash Flow | 2025-09-27 | 2025-06-28 |
|---|---|---|
| Net cash from financing activities | -33,693 | -13,716 |
| Effect of exchange rate changes on cash | 238 | 632 |
| Net change in cash and cash equivalents | 582 | -8,672 |
| Cash and cash equivalents at beginning of period | 41,582 | - |
| Cash and cash equivalents at end of period | 42,164 | - |
Bioventus Inc. (BVS)
Bioventus Inc. (BVS)